U.S., March 6 -- ClinicalTrials.gov registry received information related to the study (NCT06858332) titled 'Lipoprotein(a) Levels in Patients With Atherosclerotic Cardiovascular Diseases in Russia' on Feb. 18.
Brief Summary: This study has the purpose to answer how the Lipoprotein(a) (Lp(a)) level is distributed among Atherosclerotic cardiovascular disease (ASCVD) patients in Russia, and what is the connection between elevated levels of this parameter and the cardiovascular disease (CVD) risk.
Study Start Date: March 31
Study Type: OBSERVATIONAL
Condition:
Atherosclerotic Cardiovascular Disease
Intervention:
DRUG: Atorvastatin
3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors (statins)
DRUG: Simvastatin
3-Hydroxy-3-methylglutar...